These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 221824)
21. Opioid receptors and their ligands: natural and unnatural. Pleuvry BJ Br J Anaesth; 1991 Mar; 66(3):370-80. PubMed ID: 1673056 [No Abstract] [Full Text] [Related]
22. [Importance of the discovery of endorphins and enkephalins for present-day psychopharmacology]. Herman ZS Postepy Hig Med Dosw; 1983; 37(3):233-70. PubMed ID: 6143307 [No Abstract] [Full Text] [Related]
25. Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor. Corbett AD; Paterson SJ; McKnight AT; Magnan J; Kosterlitz HW Nature; 1982 Sep; 299(5878):79-81. PubMed ID: 6125893 [No Abstract] [Full Text] [Related]
26. Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies. Pollard H; Llorens C; Schwartz JC; Gros C; Dray F Brain Res; 1978 Aug; 151(2):392-8. PubMed ID: 209865 [No Abstract] [Full Text] [Related]
27. Opiate receptor heterogeneity in human brain regions. Bonnet KA; Groth J; Gioannini T; Cortes M; Simon EJ Brain Res; 1981 Sep; 221(2):437-40. PubMed ID: 6269694 [No Abstract] [Full Text] [Related]
28. The primate locus coeruleus and effects of clonidine on opiate withdrawal. Redmond DE; Huang YH J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):25-9. PubMed ID: 6282817 [TBL] [Abstract][Full Text] [Related]
29. Differential postnatal development of mu and delta opiate receptors. Wohltmann M; Roth BL; Coscia CJ Brain Res; 1982 Apr; 255(4):679-84. PubMed ID: 6280810 [TBL] [Abstract][Full Text] [Related]
30. Stereospecific effects of opiate antagonists on superficial and deep nociception and on motor activity suggest involvement of endorphins on different opioid receptors. Ramabadran K; Jacob JJ Life Sci; 1979 May; 24(21):1959-69. PubMed ID: 222987 [No Abstract] [Full Text] [Related]
31. [Endorphins in psychiatry]. Lajeunesse C; Villeneuve A Sem Hop; 1982 Dec; 58(44):2581-7. PubMed ID: 6297051 [No Abstract] [Full Text] [Related]
33. Pain: its physiology and rationale for management. Part II. Analgesic systems of the CNS. Bishop B Phys Ther; 1980 Jan; 60(1):21-3. PubMed ID: 6101293 [TBL] [Abstract][Full Text] [Related]
34. Basic and clinical studies of endorphins. Ann Intern Med; 1979 Aug; 91(2):239-50. PubMed ID: 37796 [No Abstract] [Full Text] [Related]
35. Current views on endogenous ligands for opiate recognition sites. Cox BM Clin Neuropharmacol; 1986; 9 Suppl 4():211-3. PubMed ID: 2882839 [No Abstract] [Full Text] [Related]
36. Opiate receptors and opioid peptides. Snyder SH; Childers SR Annu Rev Neurosci; 1979; 2():35-64. PubMed ID: 44172 [No Abstract] [Full Text] [Related]
37. Unsulfated C-terminal 7-peptide of cholecystokinin: a new ligand of the opiate receptor. Schiller PW; Lipton A; Horrobin DF; Bodanszky M Biochem Biophys Res Commun; 1978 Dec; 85(4):1332-8. PubMed ID: 217386 [No Abstract] [Full Text] [Related]
38. The changing nature of pain control. Clinical aspects of endorphins and enkephalins. Hirst M J Can Dent Assoc; 1985 Jul; 51(7):493-8. PubMed ID: 2862981 [No Abstract] [Full Text] [Related]
39. Enkephalins and endorphins: the endogenous opiates. Milloy D AANA J; 1982 Dec; 50(6):569-73. PubMed ID: 6299048 [No Abstract] [Full Text] [Related]
40. [Nerve tissue distribution and physiologic role of endogenous opioid peptides and their receptors--POMC-, proenkephalin A, proenkephalin B- derived opioid peptides and kyotorphin]. Yamada T; Nakao K; Shirakami G; Saito Y; Mukoyama M; Arai H; Hosoda K; Suga S; Jogasaki M; Ogawa Y Nihon Rinsho; 1990 May; 48(5):1042-52. PubMed ID: 2165536 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]